TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
TRiPOD:在 AD/ADRD 观察数据中实现可重复使用的表型 - 管理定义和纠正偏差
基本信息
- 批准号:10642888
- 负责人:
- 金额:$ 78.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:Active LearningAddressAffectAlgorithmsAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmericanArtificial IntelligenceCause of DeathClinical ResearchCommunitiesComplexDataData AnalysesDepositionDiseaseDrug ExposureElectronic Health RecordEngineeringEpidemiologistEtiologyEvaluationFAIR principlesGoalsHealthcareIncentivesIncidenceInformaticsInvestigationJointsKnowledgeLiteratureLong-Term CareMedicalMethodsModernizationObservational StudyOntologyOutcomePathogenesisPatientsPhenotypePreventionProbabilityProtocols documentationPublication BiasReproducibilityResearchRisk FactorsSamplingSourceStandardizationStatistical ModelsTerminologyTranslational Researchcare systemscohortcommunity engagementdata managementeffective therapyhospital servicesimprovedinsightknowledge basenovelpaymentphenotypic dataphenotyping algorithmpreventrepositoryrisk stratificationsocialtooltraittreatment responseweb portal
项目摘要
Project Summary
Large observational data such as electronic health records (EHRs) and medical claims have
become an enabling source for facilitating clinical and translational research including Alzheimer's
Disease and Alzheimer's Disease Related Dementia (AD/ADRD). One major challenge for
conducting observational AD/ADRD studies is about phenotyping – there is a lack of a centralized
repository for hosting and standardizing phenotype definitions in AD/ADRD research and few
methods have been developed to address bias associated with phenotyping errors in observation
data. Therefore, the overarching goal of this proposal is to fully develop a joint effort between
medical informaticians, statisticians, clinicians, and epidemiologists with a focus on building a
rigorous set of methods and tools for managing phenotype definitions and for correcting bias in
observational data analysis, through modern knowledge engineering and data-driven statistical
modeling. To achieve that goal, we propose three specific aims in this study: (1) Aim 1 - Collect,
normalize, and share definitions of common phenotypes used in AD/ADRD observational
research; (2) Aim 2 - Develop novel algorithms to correct bias associated with phenotyping errors
when users apply existing phenotype definitions to local data; and (3) Aim 3 - Validate, refine, and
disseminate proposed methods and tools by demonstration studies and community engagement.
We believe informatics methods and tools proposed here will improve current practice on
phenotypic data management and analysis, thus enhancing the reproducibility and quality of
observational studies on AD/ADRD.
项目摘要
大型观察性数据,如电子健康记录(EHR)和医疗索赔
成为促进包括阿尔茨海默氏症在内的临床和翻译研究的有利来源
疾病和阿尔茨海默病相关痴呆(AD/ADRD)。面临的一个主要挑战
进行观察性AD/ADRD研究是关于表型的--缺乏集中的
用于托管和标准化AD/ADRD研究中的表型定义的存储库
已经开发了一些方法来解决与观察中的表型错误相关的偏差
数据。因此,该提案的总体目标是充分发展两国之间的共同努力
医疗信息学家、统计学家、临床医生和流行病学家,重点是建立
一套严格的方法和工具,用于管理表型定义和纠正
通过现代知识工程和数据驱动的统计进行观测数据分析
模特儿。为了实现这一目标,我们在本研究中提出了三个具体目标:(1)目标1-收集,
标准化和共享AD/ADRD观测中使用的常见表型的定义
研究;(2)目标2-开发新的算法来纠正与表型错误相关的偏见
当用户将现有的表型定义应用于本地数据时;以及(3)目标3-验证、改进和
通过示范研究和社区参与传播拟议的方法和工具。
我们相信,这里提出的信息学方法和工具将改善当前的实践
表型数据管理和分析,从而提高表型数据的再现性和质量
AD/ADRD的观测研究。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Adding caplacizumab to standard of care in thrombotic thrombocytopenic purpura: a systematic review and meta-analysis.
- DOI:10.1182/bloodadvances.2022008443
- 发表时间:2023-05-23
- 期刊:
- 影响因子:7.5
- 作者:Djulbegovic, Mia;Tong, Jiayi;Xu, Alice;Yang, Joanna;Chen, Yong;Cuker, Adam;Pishko, Allyson M.
- 通讯作者:Pishko, Allyson M.
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yong Chen其他文献
Yong Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yong Chen', 18)}}的其他基金
ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
ClinEX - 临床证据提取、表示和评估
- 批准号:
10754029 - 财政年份:2023
- 资助金额:
$ 78.43万 - 项目类别:
Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity
早产儿视网膜病变的替代增强深度预测学习
- 批准号:
10740289 - 财政年份:2023
- 资助金额:
$ 78.43万 - 项目类别:
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
开发磁共振指纹图谱 (MRF) 来评估乳腺癌新辅助化疗的反应
- 批准号:
10713097 - 财政年份:2023
- 资助金额:
$ 78.43万 - 项目类别:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
肾脏磁共振指纹图谱用于肾细胞癌评估的发展
- 批准号:
10522570 - 财政年份:2022
- 资助金额:
$ 78.43万 - 项目类别:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
肾脏磁共振指纹图谱用于肾细胞癌评估的发展
- 批准号:
10707150 - 财政年份:2022
- 资助金额:
$ 78.43万 - 项目类别:
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRD
CICADA:AD/ADRD 药物重新定位的临床信息学和计算方法
- 批准号:
10476677 - 财政年份:2021
- 资助金额:
$ 78.43万 - 项目类别:
PheBC: bias correction methods for EHR derived phenotype
PheBC:EHR 衍生表型的偏差校正方法
- 批准号:
10471166 - 财政年份:2021
- 资助金额:
$ 78.43万 - 项目类别:
PheBC: bias correction methods for EHR derived phenotype
PheBC:EHR 衍生表型的偏差校正方法
- 批准号:
10839649 - 财政年份:2021
- 资助金额:
$ 78.43万 - 项目类别:
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
TRiPOD:在 AD/ADRD 观察数据中实现可重复使用的表型 - 管理定义和纠正偏差
- 批准号:
10279554 - 财政年份:2021
- 资助金额:
$ 78.43万 - 项目类别:
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRD
CICADA:AD/ADRD 药物重新定位的临床信息学和计算方法
- 批准号:
10490346 - 财政年份:2021
- 资助金额:
$ 78.43万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 78.43万 - 项目类别:
Research Grant